AG-825 is a selective, ATP-competitive, tyrosine phosphorylation ErbB2 inhibitor with an IC50 of 0.35 µM. AG825 significantly accelerates Apoptosis of human neutrophils. AG-825 increases beta1AR density. AAG-825 has anticancer and anti-inflammatory activities. AAG-825 can be used in cardiovascular disease research[1][2][3][4][5][6][7].
Molecular Weight:
397.47
Purity:
98.02
CAS Number:
[149092-50-2]
Formula:
C19H15N3O3S2
Target:
Adrenergic Receptor,Apoptosis,EGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted